NEW YORK (MainStreet)  If the company that manufactures Aminoplex is approved, Creative Edge Nutrition will soon be growing and selling marijuana to the tune of $100 million in first year revenue through its Canadian facility CEN Biotech.

"My intention is to grow enough cannabis to supply Canada and build an export market," said Bill Chaaban, CEO of Creative Edge Nutrition in Madison Heights, Mich.

CEN Biotech is a subsidiary of CEN, a U.S. publicly traded company listed on the pink sheet as FITX.

"Marijuana companies are obviously taking full advantage of the spotlight they currently enjoy and investors should consider what happens when that spotlight fades and/or the company doesn't come through on their promises just like so many penny stock companies before them," said Timothy Sykes, an entrepreneur and penny stock expert in Miami.

The CEN Biotech super grow facility is located on ten acres of land in the City of Lakeshore in Ontario that Chaaban leases for $25,000 a month from a relative and where marijuana laws are less stringent than in the U.S.

As treated by the Canadian government, marijuana is neither supplement nor drug. It's considered a hybrid with a unique regulatory framework created especially to govern medical marijuana.

"Canada will continue to liberalize their view of marijuana use," said Jim Smeeding, executive director of the National Association of Specialty Pharmacy (NASP). "Medical marijuana is already in place through Health Canada. As a result, recreational use is probably on the way."

Health Canada is the licensing entity from which CEN Biotech is seeking approval to grow and sell cannabis to Canadians and to those in the U.S. and other countries abroad, such as Israel and Uruguay.

"The cannabis we produce will be tested in labs approved by Health Canada," Chaaban told MainStreet.

Demand from the U.S. could dwarf Canadian demand by 50 million pounds of cannabis a year and while other growers produce 30,000 to 40,000 pounds of marijuana annually, Chaaban projects CEN Biotech will produce 1.3 million pounds annually.

"We started the application process in April 2012," said Chaaban, an attorney and entrepreneur who is a dual citizen of the U.S. and Canada. "We are at the ready to build stage but we don't have a license yet."

Currently, U.S. dispensaries are required to grow 70% of the cannabis they sell, which limits their supply.

"California and Colorado dispensaries will not be able to satisfy the demand for marijuana so we are preparing for this onslaught of demand by growing cannabis in clean rooms with air filtration, free of mold, lights and metals," Chaaban said.

Typically, 60 to 90 days is needed to grow a cannabis plant; however, a patent obtained through RXNB will shorten that time for CEN Biotech.

"The RXNB patent will facilitate a 35 day growth cycle that will yield four or five times more cannabis," said Chaaban. "That significantly reduces the traditional grow cycle for medical marijuana."

Chaaban is hoping that the U.S. federal government will legalize marijuana before the next presidential election. Meanwhile, the plant is costing $12 million to build.

--Written by Juliette Fairley for MainStreet